Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

By Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering ...

Cell division is an essential biological process that removes aged cells and continuously renews tissues. In the human body, billions of cells divide each day: intestinal cells are completely renewed ...

The US Department of Health and Human Services is demanding that pharmaceutical companies cut drug prices to the lowest price ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.